文献速递皮肤肿瘤

皮肤鳞状细胞癌进展过程中长链非编码RNA的图谱

The landscape of long noncoding RNA during cutaneous squamous cell carcinoma progression.
PubMed 文献 · Br J Dermatol · 2025-01-01

该研究对110例样本(包括健康暴晒皮肤、光化性角化病、原发性cSCC和转移灶)进行批量RNA测序,描绘了cSCC疾病连续过程中的lncRNA表达图谱。研究发现lncRNA表达本身足以识别疾病状态和进展,并开发了与祖细胞样状态相关的267个lncRNA特征,可预测头颈鳞癌和胰腺腺癌的不良预后。敲低LINC00941表明其是体外细胞增殖和集落形成所必需的。

要点

  • lncRNA表达谱可区分cSCC不同阶段及疾病连续过程。
  • 267个lncRNA特征与祖细胞样状态相关,可预测HNSC和PAAD不良预后。
  • LINC00941敲低抑制cSCC细胞体外增殖和集落形成。

核心结论

  • lncRNA表达变化足以识别cSCC疾病状态和进展,并可能作为生物标志物和驱动因素。

研究设计与样本

  • 研究对110例患者样本进行批量RNA测序,包括健康暴晒皮肤26例、光化性角化病14例、原发性cSCC 66例和转移灶4例。
  • 对15例患者来源细胞系进行批量RNA测序,并在多个其他cSCC基因表达队列中验证发现。
  • 使用生物信息学流程基于共表达模式推断lncRNA功能,并生成lncRNA特征评分。

主要发现

  • lncRNA表达本身足以识别cSCC疾病连续过程中的疾病状态和进展。
  • 研究开发了267个lncRNA特征,与祖细胞样状态相关,并在HNSC和PAAD中预测不良预后。
  • 患者来源细胞系的批量RNA测序揭示了肿瘤细胞特异性lncRNA。
  • 敲低LINC00941表明其是体外细胞增殖和集落形成所必需的。

关键数值与推荐

  • 267个lncRNA特征评分与祖细胞样状态相关,并在HNSC和PAAD中预测不良预后。

临床怎么用

  • lncRNA表达谱可能用于识别cSCC疾病状态和进展阶段。
  • 267个lncRNA特征可能作为预测HNSC和PAAD预后的工具。
  • LINC00941可能成为cSCC治疗的潜在靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cutaneous squamous cell carcinoma (cSCC) is a common cancer with a high morbidity rate and poor prognosis for metastatic disease. Disease may progress from premalignant actinic keratosis to invasive and metastatic cSCC, but it is perhaps best characterized as a disease continuum progressing from a differentiated to a progenitor-like state. The critical molecular mediators of this process remain poorly defined. Long noncoding (lnc)RNAs, a relatively unexplored class of RNA molecules > 200 nucleotides long, are likely to have important functional roles in cSCC. OBJECTIVES: To provide a comprehensive landscape of lncRNA expression during the cSCC continuum and to identify potentially functional lncRNA drivers of disease progression. METHODS: We interrogated bulk RNA sequencing (RNAseq) data from 110 patient samples, encompassing healthy sun-exposed skin (n = 26), actinic keratosis (n = 14), primary cSCC (n = 66) and metastases (n = 4), to identify changes in lncRNA expression during disease progression. We developed a bioinformatics pipeline to infer lncRNA function based on co-expression patterns and generated a lncRNA signature score, which we validated in head-and-neck squamous cell carcinoma (HNSC) and pancreatic adenocarcinoma (PAAD). We performed bulk RNAseq on 15 patient-derived cell lines and integrated these data to identify tumour cell-specific lncRNAs and validated our findings in multiple other cSCC gene expression cohorts. Using in vitro knockdown approaches we investigated the functional role of LINC00941. RESULTS: We found that lncRNA expression alone is sufficient to identify disease states and progression along the cSCC disease continuum. Correlation analysis revealed potentially functionally relevant lncRNAs and the processes they may regulate. We developed a 267 lncRNA signature that correlates with a progenitor-like state and predicts poor prognosis in HNSC and PAAD. Bulk RNAseq of patient-derived cell lines revealed tumour cell-specific lncRNAs, and knockdown of LINC00941 indicated that it is required for cell proliferation and colony formation in vitro. CONCLUSIONS: Our findings provide a comprehensive description of lncRNA transcriptomic changes in cSCC and demonstrate their functional relevance as biomarkers and drivers of disease progression in this and, potentially, other cancers. Cutaneous squamous cell carcinoma (or ‘cSCC’ for short) is a type of skin cancer. It is one of the most common cancers worldwide. cSCC is usually caused by prolonged skin exposure to ultraviolet (UV) light (sunlight). This damages the genetic material of skin cells and leads to mutations that cause cancer. Mutations to a specific type of skin cell known as ‘keratinocytes’ lead to the formation of pre-cancerous lesions known as ‘actinic keratoses’. cSCC commonly develops from these lesions. cSCC is usually treated by removing it surgically. However, if it is left untreated, it can become invasive and grow as tumours in other parts of the body. When this happens, it is known as ‘metastatic cSCC’ and the prognosis for the patient is much worse. This will happen in about 1% to 5% of people with cSCC. Treatment in these cases is limited. In our study, we looked at a specific family of genes called ‘long non-coding RNAs’ (lncRNAs). We did this to try and understand how they might contribute to the progression of cSCC. To do this, we studied lncRNA expression in healthy skin and compared the information with skin affected by cSCC. We found that lncRNA expression is enough to tell us about the stage of cSCC development. We identified 267 lncRNAs that may be important in the disease progression of cSCC. We developed a scoring system for these lncRNAs and showed how this can help with the prognosis of head and neck cancer and in pancreatic cancer. We looked in detail at the function of one of these lncRNA molecules (called ‘LINC00941’) and found that it is required for cancer cells to grow. Our findings include a description of lncRNA changes in cSCC. They also show how lncRNAs could be used to spot the disease and understand how it progresses.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Bone M, Schreyer D, Treanor-Taylor M, et al. The landscape of long noncoding RNA during cutaneous squamous cell carcinoma progression. Br J Dermatol. 2025. PMID: 40152495. doi:10.1093/bjd/ljaf108

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。